GVK Bio, LifeArc advance research in medicine

Hyderabad: GVK BIO, a global contract research and development organisation (CRDO), and LifeArc, a UK-based medical research charity, on Wednesday said they completed 10 years of partnership, wherein the collaboration was aimed at advancing research ideas into potential medicines.

LifeArc said its approach involves partnerships with academia and service organisations to advance discoveries into promising medicines.

"Our scientific teams focus their efforts on modulating targets with therapeutic potential in diseases where there is patient need.

The GVK Bio team has assisted in synthesizing complex molecules rapidly and cost-effectively to drive improvement in efficacy and safety," LifeArc added.

Melanie Lee, CEO, LifeArc, said: "At LifeArc, we are committed to translating scientific innovation to benefit patients.

Our partnership with GVK Bio is an example of how shared goals and collaboration can create value."

Under this partnership, medicines such as Keytruda, Tysabri, Entyvio among others have been delivered.